GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tandem Diabetes Care Inc (MEX:TNDM) » Definitions » Cyclically Adjusted PS Ratio

Tandem Diabetes Care (MEX:TNDM) Cyclically Adjusted PS Ratio : 1.97 (As of Jun. 24, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Tandem Diabetes Care Cyclically Adjusted PS Ratio?

As of today (2024-06-24), Tandem Diabetes Care's current share price is MXN807.19. Tandem Diabetes Care's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was MXN410.09. Tandem Diabetes Care's Cyclically Adjusted PS Ratio for today is 1.97.

The historical rank and industry rank for Tandem Diabetes Care's Cyclically Adjusted PS Ratio or its related term are showing as below:

MEX:TNDM' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.79   Med: 2.27   Max: 8.81
Current: 2.38

During the past years, Tandem Diabetes Care's highest Cyclically Adjusted PS Ratio was 8.81. The lowest was 0.79. And the median was 2.27.

MEX:TNDM's Cyclically Adjusted PS Ratio is ranked worse than
52.51% of 478 companies
in the Medical Devices & Instruments industry
Industry Median: 2.075 vs MEX:TNDM: 2.38

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Tandem Diabetes Care's adjusted revenue per share data for the three months ended in Mar. 2024 was MXN48.695. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is MXN410.09 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Tandem Diabetes Care Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Tandem Diabetes Care's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tandem Diabetes Care Cyclically Adjusted PS Ratio Chart

Tandem Diabetes Care Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 8.81 2.46 1.66

Tandem Diabetes Care Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.22 1.35 1.14 1.66 1.97

Competitive Comparison of Tandem Diabetes Care's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, Tandem Diabetes Care's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tandem Diabetes Care's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Tandem Diabetes Care's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Tandem Diabetes Care's Cyclically Adjusted PS Ratio falls into.



Tandem Diabetes Care Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Tandem Diabetes Care's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=807.19/410.09
=1.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tandem Diabetes Care's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Tandem Diabetes Care's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=48.695/131.7762*131.7762
=48.695

Current CPI (Mar. 2024) = 131.7762.

Tandem Diabetes Care Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 57.577 100.560 75.451
201409 77.312 100.428 101.445
201412 111.895 99.070 148.836
201503 73.525 99.621 97.257
201506 82.418 100.684 107.870
201509 88.405 100.392 116.042
201512 165.966 99.792 219.159
201603 113.991 100.470 149.510
201606 139.414 101.688 180.665
201609 77.601 101.861 100.391
201612 193.093 101.863 249.798
201703 112.047 102.862 143.543
201706 77.040 103.349 98.231
201709 94.422 104.136 119.484
201712 78.207 104.011 99.084
201803 27.542 105.290 34.470
201806 13.162 106.317 16.314
201809 15.560 106.507 19.252
201812 26.004 105.998 32.328
201903 22.159 107.251 27.226
201906 30.769 108.070 37.519
201909 31.568 108.329 38.401
201912 34.520 108.420 41.956
202003 38.436 108.902 46.509
202006 41.728 108.767 50.555
202009 44.378 109.815 53.253
202012 53.700 109.897 64.391
202103 46.165 111.754 54.436
202106 52.185 114.631 59.990
202109 57.012 115.734 64.914
202112 66.477 117.630 74.472
202203 54.829 121.301 59.564
202206 62.874 125.017 66.273
202209 64.051 125.227 67.401
202212 66.767 125.222 70.262
202303 47.299 127.348 48.944
202306 51.809 128.729 53.036
202309 49.654 129.860 50.387
202312 51.098 129.419 52.029
202403 48.695 131.776 48.695

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Tandem Diabetes Care  (MEX:TNDM) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Tandem Diabetes Care Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Tandem Diabetes Care's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Tandem Diabetes Care (MEX:TNDM) Business Description

Traded in Other Exchanges
Address
11075 Roselle Street, San Diego, CA, USA, 92121
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. Nearly three quarters of total revenue is derived from the U.S., with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Tandem Diabetes Care (MEX:TNDM) Headlines

From GuruFocus